Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
Clinical Pharmacology and Therapeutics|April 9, 2025
Participants in the FDA's Biomarker Qualification ProgramMahnum Shahzad, Ariel D SternHealth Affairs (Project Hope)|August 17, 2022
Accelerated Approval Of Cancer Drugs: No Economic Reward For Drug Makers That Conduct Confirmatory TrialsRichard G Frank, Mahnum Shahzad, Ezekiel J EmanuelHealth Economics|January 13, 2022
Biosimilar competition: Early learningRichard G Frank, Mahnum Shahzad, Aaron S Kesselheim, et al.The American Journal of Managed Care|November 14, 2022
Changes in use of low-value services during the COVID-19 pandemicMahnum Shahzad, Zirui Song, Michael E Chernew, et al.Clinical Pharmacology and Therapeutics|April 2, 2024
Tracing Digital Therapeutics Research Across Medical Specialties: Evidence from ClinicalTrials.govLars Masanneck, Ariel D SternClinical Pharmacology and Therapeutics|February 3, 2024
Tepid Uptake of Digital Health Technologies in Clinical Trials by Pharmaceutical and Medical Device FirmsCaroline Marra, Ariel D SternJournal of Pharmaceutical Policy and Practice|June 6, 2024
Regulatory histories of recently withdrawn ovarian cancer treatment indications of 3 PARP inhibitors in the US and Europe: lessons for the accelerated approval pathwayMahnum Shahzad, Huseyin Naci, Katharine M Esselen, et al.Health Affairs (Project Hope)|September 6, 2022
Rapid Growth Of Remote Patient Monitoring Is Driven By A Small Number Of Primary Care ProvidersMitchell Tang, Ateev Mehrotra, Ariel D SternNPJ Digital Medicine|July 21, 2020
Germany's digital health reforms in the COVID-19 era: lessons and opportunities for other countriesSara Gerke, Ariel D Stern, Timo MinssenClinical Pharmacology and Therapeutics|October 17, 2017
Innovation Incentives and BiomarkersAriel D Stern, Brian M Alexander, Amitabh ChandraPageof 4